| P50 | author | Sarit Golub | Q90188547 |
| | Jeffrey T. Parsons | Q39673170 |
| | William Kowalczyk | Q43165856 |
| P2093 | author name string | Michael Botsko | |
| | Julia Tomassilli | |
| P2860 | cites work | Mirtazapine to reduce methamphetamine use: a randomized controlled trial | Q24603456 |
| | A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine | Q27027539 |
| | Longitudinal modeling of methamphetamine use and sexual risk behaviors in gay and bisexual men | Q28288762 |
| | Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts | Q28477883 |
| | A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users | Q30426188 |
| | Alcohol and sexual HIV risk behavior among problem drinking men who have sex with men: An event level analysis of timeline followback data. | Q31032486 |
| | A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence | Q33254470 |
| | The analysis of count data: a gentle introduction to poisson regression and its alternatives | Q33407452 |
| | Alcohol use and antiretroviral adherence: review and meta-analysis | Q33625797 |
| | Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial | Q33776235 |
| | The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients | Q33797580 |
| | Drug use and medication adherence among HIV-1 infected individuals | Q33841530 |
| | Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida | Q33853689 |
| | Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity | Q33855976 |
| | Recruiting hard-to-reach drug-using men who have sex with men into an intervention study: lessons learned and implications for applied research | Q33867743 |
| | The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties | Q33892914 |
| | Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse | Q33917628 |
| | Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users | Q33939975 |
| | Contingency management among homeless, out-of-treatment men who have sex with men | Q34117642 |
| | Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study | Q34126545 |
| | Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with men. | Q34129231 |
| | Treatment as prevention--a double hat-trick | Q34201017 |
| | Behaviors of recently HIV-infected men who have sex with men in the year postdiagnosis: effects of drug use and partner types | Q34500871 |
| | Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence | Q34629825 |
| | Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV | Q34634551 |
| | Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls | Q35034399 |
| | Adherence to antiretroviral therapy: are we doing enough? | Q35129834 |
| | Substance abuse and medication adherence among HIV-positive women with histories of child sexual abuse | Q35429075 |
| | Patient-related factors predicting HIV medication adherence among men and women with alcohol problems | Q35758118 |
| | Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy | Q44692012 |
| | The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment | Q44693763 |
| | Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers | Q44714901 |
| | Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study. | Q44820800 |
| | Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women | Q44831221 |
| | HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. | Q45187803 |
| | Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea | Q45193918 |
| | A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care | Q45333065 |
| | Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006. | Q46010875 |
| | Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance | Q46132342 |
| | Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy | Q46159115 |
| | Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco | Q46240579 |
| | Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression | Q46474715 |
| | Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program | Q46722261 |
| | A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals | Q46918312 |
| | Risk factors for HIV infection among men who have sex with men. | Q46973550 |
| | Contingency management for the treatment of methamphetamine use disorders. | Q52003170 |
| | Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy | Q61602523 |
| | Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients | Q81488021 |
| | Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE study | Q35865410 |
| | The critical role of intimacy in the sexual risk behaviors of gay and bisexual men. | Q36036035 |
| | Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence | Q36303691 |
| | The methamphetamine epidemic: implications for HIV prevention and treatment | Q36338896 |
| | The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study | Q36364740 |
| | Psychiatric Risk Factors for HIV Disease Progression: The Role of Inconsistent Patterns of Antiretroviral Therapy Utilization | Q36389710 |
| | Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study | Q36622823 |
| | Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication | Q36666541 |
| | Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men. | Q36748790 |
| | Evolution of HIV dementia with HIV infection | Q37073653 |
| | Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: a randomized clinical trial | Q37080252 |
| | Medication adherence mediates the relationship between adherence self-efficacy and biological assessments of HIV health among those with alcohol use disorders | Q37152788 |
| | The temporal relationship between alcohol consumption and HIV-medication adherence: a multilevel model of direct and moderating effects | Q37152791 |
| | Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates. | Q37185943 |
| | Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis | Q37330136 |
| | Randomized trial to reduce club drug use and HIV risk behaviors among men who have sex with men. | Q37379262 |
| | Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis | Q37452644 |
| | Substance use: impact on adherence and HIV medical treatment | Q37920746 |
| | A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. | Q37983020 |
| | Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability. | Q38452483 |
| | Adherence to protease inhibitor therapy and outcomes in patients with HIV infection | Q39605935 |
| | Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death | Q39702981 |
| | Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. | Q39714312 |
| | In the shadows of a prevention campaign: sexual risk behavior in the absence of crystal methamphetamine | Q39837129 |
| | Prospective memory impairment in former users of methamphetamine | Q40024568 |
| | Experiences and sexual behaviors of HIV-infected MSM who acquired HIV in the context of crystal methamphetamine use. | Q40118084 |
| | The validity of self-reported drug use in survey research: an overview and critique of research methods | Q41551156 |
| | Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection | Q42490835 |
| | HIV antiviral drug resistance: patient comprehension | Q43690728 |
| | Predictors of nonadherence to HIV-related medication regimens during methadone stabilization | Q43940594 |
| | Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection | Q44445534 |
| | Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men | Q44655783 |
| P433 | issue | 4 | |
| P304 | page(s) | 1478-1487 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | AIDS and Behavior | Q15752229 |
| P1476 | title | Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men. | |
| P478 | volume | 17 | |